BD announces $110 million investment in Nebraska to expand prefillable syringe production
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
Dr. Reddy’s Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% is an antihistamine eye drop, indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander
The integration unifies brand and field strategy, drives executional alignment, and delivers immediate impact measurement
The deal brings Labcorp’s U.S. portfolio—including biocompatibility, microbiological, and analytical testing, as well as preclinical research—under NAMSA’s roof
Supports production of AbbVie's current and next-generation immunology and neuroscience medicines
The multimillion-dollar facility combines discovery and early-phase scale-up capabilities with R&D labs and two pilot plants
InflaRx is streamlining operations and largely discontinuing non-essential activities outside izicopan’s development
Subscribe To Our Newsletter & Stay Updated